MULTIPLE SYSTEM ATROPHY
Clinical trials for MULTIPLE SYSTEM ATROPHY explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SYSTEM ATROPHY trials appear
Sign up with your email to follow new studies for MULTIPLE SYSTEM ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a vaccine slow Parkinson's? early trial shows promise
⭐️ VACCINE ⭐️ CompletedThis early-phase study tested a vaccine called UB-312 in 8 people with Parkinson's disease or multiple system atrophy. The goal was to see if the vaccine is safe and helps the body make antibodies against a harmful protein linked to these brain diseases. The study focused on safe…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: PHASE1 • Sponsor: NYU Langone Health • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:02 UTC
-
Brain scan breakthrough could catch Parkinson's before symptoms worsen
Diagnosis CompletedThis completed study tested a new PET imaging agent, [18F]-FD17, to detect abnormal alpha-synuclein protein clumps in the brain. Researchers scanned 55 people, including healthy volunteers and patients with Parkinson's disease, multiple system atrophy, or REM sleep behavior disor…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated May 17, 2026 04:13 UTC
-
Inflatable belt lifts blood pressure in standing challenge
Symptom relief CompletedThis study tested a special inflatable belt worn around the belly that automatically tightens to help raise blood pressure when standing. It included 28 adults aged 40-80 with autonomic failure and disabling low blood pressure upon standing. The goal was to see if the device safe…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: PHASE1, PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated May 17, 2026 04:11 UTC
-
New hope for MSA patients: drug eases dangerous blood pressure drops
Symptom relief CompletedThis study tested a drug called droxidopa (L-threo DOPS) to see if it could reduce symptoms of orthostatic hypotension—dizziness and fainting when standing up—in people with multiple system atrophy (MSA). Over 100 adults with MSA took either the drug or a placebo for 12 weeks. Th…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated May 11, 2026 20:49 UTC
-
Belly bands may beat meds for standing dizziness
Knowledge-focused CompletedThis study looked at how squeezing the belly with a special band helps people with a condition that causes blood pressure to drop when they stand up. 21 adults with autonomic failure participated. The goal was to understand why this simple method works, comparing it to a standard…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: PHASE1 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Belly bands vs pills: which lowers heart risk in rare nerve disorder?
Knowledge-focused CompletedThis study looked at how two common treatments for low blood pressure upon standing—a medication called midodrine and an abdominal compression binder—affect heart health markers. Researchers measured things like pulse wave velocity and central blood pressure in 31 adults with aut…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Why do MSA patients feel pain? scientists investigate
Knowledge-focused CompletedThis study looked at why people with multiple system atrophy (MSA) often feel pain. Researchers measured pain thresholds in 42 participants, including MSA patients, Parkinson's disease patients, and healthy volunteers. They used heat stimulation and reflex tests to see if levodop…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC
-
New education program for rare brain disease shows promise in small study
Knowledge-focused CompletedThis study tested whether a 12-month educational program is practical for people with Multiple System Atrophy (MSA) and their caregivers. The program included in-person visits and online activities to help them understand symptoms and cope. Only 15 patient-caregiver pairs took pa…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC